April 13, 2021
Passing of Genmab A/S’ Annual General Meeting
Company Announcement At Genmab A/S’ Annual General Meeting held today April 13, 2021, the Annual Report for 2020 was approvedDischarge…
Pharmaceuticals, Biotechnology and Life Sciences
Company Announcement At Genmab A/S’ Annual General Meeting held today April 13, 2021, the Annual Report for 2020 was approvedDischarge…
Pursuant to the decision of the shareholders’ meeting of September 22, 2020, the Management Board of JSC Olainfarm has filed…
SEATTLE, April 13, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived live tumor…
WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) — We are developing the infrastructure of a global zoonotic infectious diseases “alert…
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies…
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential…
– Appointment strengthens leadership team as the Company readies for potential global odevixibat launch and progresses multiple clinical development programs…
Phase 1b/2a Study Expected to Begin In 2Q 2021DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc.…
– Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational…
Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK Reported Positive Pre-Clinical Data Associated with…